National Institutes of Health logo
Program

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Therapeutic Agent Characterization and Preclinical Efficacy Studies

Funds pharmacodynamic, pharmacokinetic and efficacy testing that shows a therapeutic agent has enough biological activity to justify further development.

A therapeutic idea that looks good on paper still has to prove it does something real inside a living system before anyone invests in taking it further.

This half of the IGNITE pair funds exactly that proof: pharmacodynamic, pharmacokinetic and efficacy studies on a therapeutic agent — a small molecule or a biologic — to show it has enough biological activity to warrant further development. That

Biotech

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.

Last verified: 27 Aug 2026Source: www.grants.gov